A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

In immune-mediated inflammatory diseases, the overall risk for serious adverse events is not notably higher with combo ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

Scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into 'cold' tumors and flip on an immune ...

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

TIL therapy is FDA-approved as a second or third option for patients with advanced melanoma. Gibney said in the future, the ...

Approximately 80% of individuals who receive immune checkpoint inhibitors for advanced cancer do not respond to therapy, according to results of a cross-sectional analysis.The number of FDA-approved ...

Clinical characteristics were associated with different survival outcomes in patients treated with immune checkpoint ...

This population of immune cells is directly responsible for ... longer than those without the transfusion. This suggests the therapy could offer long-lasting protection against pancreatic cancer ...